Paige Butler

Researcher Spotlight: Robert Albero Gallego, PhD COLUMBIA UNIVERSITY Angioimmunoblastic T-cell lymphomas (AITLs) are aggressive forms of blood cancer and are often resistant to conventional chemotherapy. Certain mutations have been to be very common in AITLs, including mutations in the TET2…

Researcher Spotlight: Haopeng Yang, PhD UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER Super-enhancers are regions of the genome responsible for regulating expression of an unusually high number of genes. For his Lymphoma Research Foundation-funded project, Dr. Yang is characterizing the…

Researcher Spotlight: Min Xia, PhD WEILL CORNELL MEDICINE Among the different subtypes of diffuse large B-cell lymphoma (DLBCL), ABC-DLBCL represents one of the most aggressive forms with low response rates to standard chemotherapeutic approaches. Improved treatment approaches in this space…

Researcher Spotlight: Christoph Weigel, PhD THE OHIO STATE UNIVERSITY Epstein-Barr Virus (EBV) is a ubiquitous virus that infects many people across the globe without any serious or immediate symptoms. In certain circumstances, however, such as older age or after organ…

Researcher Spotlight: David Russler-Germain, MD, PhD WASHINGTON UNIVERSITY IN ST. LOUIS Follicular lymphoma (FL) is typically a slow-growing disease with high response rates to initial therapy, but disease outcomes vary considerably from patient to patient. Dr. Russler-Germain, therefore, is researching…